AU2002314255A1 - Peptide vector for transferring molecules of interest to eurocaryotic cells - Google Patents

Peptide vector for transferring molecules of interest to eurocaryotic cells

Info

Publication number
AU2002314255A1
AU2002314255A1 AU2002314255A AU2002314255A AU2002314255A1 AU 2002314255 A1 AU2002314255 A1 AU 2002314255A1 AU 2002314255 A AU2002314255 A AU 2002314255A AU 2002314255 A AU2002314255 A AU 2002314255A AU 2002314255 A1 AU2002314255 A1 AU 2002314255A1
Authority
AU
Australia
Prior art keywords
eurocaryotic
interest
cells
peptide vector
transferring molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002314255A
Other languages
English (en)
Inventor
Burkhard Bechinger
Antoine Kichler
Christian Leborgne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Genethon
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Genethon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV, Genethon filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU2002314255A1 publication Critical patent/AU2002314255A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AU2002314255A 2001-05-29 2002-05-27 Peptide vector for transferring molecules of interest to eurocaryotic cells Abandoned AU2002314255A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/06959 2001-05-29
FR0106959A FR2825364A1 (fr) 2001-05-29 2001-05-29 Vecteur peptiidique pour le transfert d'acides nucleiques dans des cellules eucaryotes
PCT/FR2002/001772 WO2002096928A2 (fr) 2001-05-29 2002-05-27 Vecteur peptidique pour le transfert de molecules d'interêt dans des cellules eucaryotes

Publications (1)

Publication Number Publication Date
AU2002314255A1 true AU2002314255A1 (en) 2002-12-09

Family

ID=8863702

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002314255A Abandoned AU2002314255A1 (en) 2001-05-29 2002-05-27 Peptide vector for transferring molecules of interest to eurocaryotic cells

Country Status (3)

Country Link
AU (1) AU2002314255A1 (fr)
FR (1) FR2825364A1 (fr)
WO (1) WO2002096928A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6175055B2 (ja) * 2011-06-30 2017-08-02 ジェネトン ウイルス感染増強特性を有するペプチドおよびその使用
WO2014201118A2 (fr) * 2013-06-11 2014-12-18 Sanford-Burnham Medical Research Institute Compositions et méthodes de traitement ciblé de l'endométriose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2133323C (fr) * 1992-04-03 2010-10-26 Francis C. Szoka, Jr. Systeme de distribution de polynucleotide avec autoassemblage
FR2715847B1 (fr) * 1994-02-08 1996-04-12 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
US5830730A (en) * 1997-05-08 1998-11-03 The Regents Of The University Of California Enhanced adenovirus-assisted transfection composition and method
JP2001500897A (ja) * 1997-06-10 2001-01-23 ジエンザイム コーポレイション 治療用分子の細胞内送達のための陽イオン性両親媒性組成物
AU759636B2 (en) * 1997-07-31 2003-04-17 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
WO1999042091A2 (fr) * 1998-02-19 1999-08-26 Massachusetts Institute Of Technology Compositions d'apport dans des cellules
EP1161957A1 (fr) * 2000-05-26 2001-12-12 Transgene S.A. Complexe pour le transfert d'une substance anionique d' intérêt dans une cellule

Also Published As

Publication number Publication date
WO2002096928A2 (fr) 2002-12-05
WO2002096928A3 (fr) 2004-02-26
FR2825364A1 (fr) 2002-12-06

Similar Documents

Publication Publication Date Title
AU2002258941A1 (en) Methods of enhancing cell responsiveness
WO2002083859A8 (fr) Proteines de surface de streptococcus pyogenes
AU2002233633A1 (en) Method of transferring selected molecules
AU2001290273A1 (en) Paramyxovirus vector for transferring foreign gene into skeletal muscle
AU2001261280A1 (en) Coumermycin analogs as chemical dimerizers of chimeric proteins
AU2002243972A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002300166A1 (en) Process for the Preparation of Peptides
AU2002314293A1 (en) Application of images to surfaces
AU2003901316A0 (en) Regulation of cell surface proteins
AU2002314255A1 (en) Peptide vector for transferring molecules of interest to eurocaryotic cells
WO2004081030A8 (fr) Peptides selectivement letaux pour les cellules malignes et transformees
AU2002358142A1 (en) Low-dust solid fuel preparations
AU2002319460A1 (en) Improvement of gene expression in vectors
AU2002317041A1 (en) TOPICAL ANTIINFLAMMATORY PREPARATIONS OF Gamma-TERPINENE
AU2003254935A1 (en) Novel expression vector suitable for expression of recombinant protein at low temperature
AU2000269179A1 (en) Use of colostrinin, constituent peptides thereof, and analogs thereof to promoteneural cell differentiation
AU2001257157A1 (en) Novel cell systems having specific interaction of peptide binding pairs
AU2003269055A1 (en) Vectors for transferring molecules of interest in target cells
AU2003279264A1 (en) Vector representation of polarization dependent loss
AU2002339859A1 (en) Compositions and methods relating to colon specific genes and proteins
AU2002359817A1 (en) Compositions and methods relating to gastric specific genes and proteins
AU2001249992A1 (en) Implementation of quantization for simd architecture
AU2002254731A1 (en) Method to treat hemophilia by hepatic gene transfer of factor viii/ix with vesicle vector
AU2002344252A1 (en) Mammalian diabetes-mediating proteins
AU2003245571A1 (en) Preparation of protected amino acids

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase